BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37620916)

  • 1. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
    Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
    Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.
    Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J
    J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology.
    Ishiguro Y; Tsunnemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N
    Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
    Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
    Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
    Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
    Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles.
    Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J
    Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis.
    Sheng L; Stewart T; Yang D; Thorland E; Soltys D; Aro P; Khrisat T; Xie Z; Li N; Liu Z; Tian C; Bercow M; Matsumoto J; Zabetian CP; Peskind E; Quinn JF; Shi M; Zhang J
    Acta Neuropathol Commun; 2020 Jul; 8(1):102. PubMed ID: 32641150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].
    Yan XM; Li PJ; Li W; Wang XM; Yu S
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052
    [No Abstract]   [Full Text] [Related]  

  • 11. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
    Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
    Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
    J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
    Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Front Immunol; 2019; 10():2253. PubMed ID: 31616427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
    Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
    Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.
    Yu Z; Shi M; Stewart T; Fernagut PO; Huang Y; Tian C; Dehay B; Atik A; Yang D; De Giorgi F; Ichas F; Canron MH; Ceravolo R; Frosini D; Kim HJ; Feng T; Meissner WG; Zhang J
    Brain; 2020 Jun; 143(6):1780-1797. PubMed ID: 32428221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice.
    Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z
    Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.